Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Traffic-related air...

    Traffic-related air pollution linked to 1 in 10 cases of childhood asthma every year: Lancet

    Written by Hina Zahid Published On 2019-04-15T19:25:43+05:30  |  Updated On 15 April 2019 7:25 PM IST
    Traffic-related air pollution linked to 1 in 10 cases of childhood asthma every year: Lancet

    Childhood asthma is one of the most common serious chronic diseases in infants and children. It is not only difficult to diagnose but is incurable as in adults. The condition is one of the leading causes of emergency department visits, hospitalizations and missed school days in children. Although there is no proven way to pinpoint the cause of asthma heredity plays a major role along with factors that trigger the attacks lie known allergens, pollens, dust, smoke and pollution lately has been an established factor for precipitating an attack of asthma or aggravating it.


    Traffic-related air pollution is associated with 4 million new cases of childhood asthma every year, according to a health impact assessment of children in 194 countries and 125 major cities worldwide. The first global estimates of their kind suggest that more than one in ten childhood asthma cases could be linked to traffic-related air pollution every year. The report has been published in The Lancet Planetary Health journal.




    • Globally, the estimates suggest that there are 170 new cases of traffic pollution-related asthma per 100,000 children every year, and 13% of childhood asthma cases diagnosed each year are linked to traffic pollution

    • The country with the highest proportion of traffic pollution-attributable childhood asthma incidence was South Korea (31%), the UK ranked 24th out of 194 countries, the US 25th, China 19th, and India 58th

    • Of the 125 cities studied, there was a large variation in the proportion of childhood asthma cases attributable to traffic pollution - from 6% in Orlu, Nigeria, to 48% in Shanghai, China. Of the ten cities with the highest proportion of cases, eight were in China, alongside Moscow, Russia, and Seoul, South Korea

    • Authors suggest that pollution guidelines may need to be re-evaluated, as most children developing traffic pollution-related asthma lived in areas within recommended levels


    With 92% of cases developing in areas that have traffic pollution levels below the WHO guideline level, the authors suggest that this limit may need to be reviewed.


    "Nitrogen dioxide pollution appears to be a substantial risk factor for childhood asthma incidence in both developed and developing countries, especially in urban areas," says senior author Dr Susan Anenberg, George Washington University, USA. "Our findings suggest that the World Health Organization guideline for annual average NO2 concentrations might need to be revisited, and that traffic emissions should be a target to mitigate exposure."


    Lead author Ploy Achakulwisut, George Washington University, USA, adds: "Our study indicates that policy initiatives to alleviate traffic-related air pollution can lead to improvements in children's health and also reduce greenhouse gas emissions. Recent examples include Shenzhen's electrification of its entire bus fleet and London's Ultra-Low Emission Zone congestion charges."


    Globally, asthma is the most common non-communicable disease among children, and, according to the WHO, prevalence has increased dramatically since the 1950s. The reasons for this are multiple.


    Traffic-related air pollution may result in asthma development as pollutants may cause damage to the airways, leading to inflammation that triggers asthma in genetically predisposed children. Although it is not yet clear which specific pollutant within the traffic-related air pollution mixture is the source of asthma development, reviews by the US Environmental Protection Agency and Health Canada suggest that a causal relationship is likely to exist between long-term nitrogen dioxide (NO2) exposure and childhood asthma development.


    In the new study, the authors used NO2 as a surrogate for the traffic pollution mixture to focus specifically on the effects of traffic pollution on childhood asthma development. NO2 is a pollutant formed mainly from fossil fuel combustion, and traffic emissions can contribute up to 80% of ambient NO2 in cities. NO2 is just one component of air pollution, which is made up of many pollutants (including particulate matter, ozone, carbon monoxide), which are known to have numerous adverse effects on health.


    The authors combined a global dataset of ambient NO2 (modelled from ground-level monitors, satellite data, and land use variables such as road networks) with data on population distribution and asthma incidence to estimate the number of new traffic pollution-related asthma cases in children aged 1-18 years.


    Globally, the estimates suggest that there are 170 new cases of traffic pollution-related asthma per 100,000 children every year, and 13% of childhood asthma cases diagnosed each year are linked to traffic pollution.


    The country with the highest rate of traffic pollution-related childhood asthma was Kuwait (550 cases per 100,000 children each year), followed by the United Arab Emirates (460 per 100,000), and Canada (450 per 100,000). Of the 125 cities studied, there was a large variation in the estimated rate of traffic pollution-related childhood asthma - from 83 cases per 100,000 children every year in Orlu, Nigeria, to 690 cases per 100,000 children in Lima, Peru. These rates of traffic pollution-related asthma are influenced by asthma rates overall, as well as pollution levels, and may underestimate true levels in many low- and middle-income countries. This is because asthma cases often go undiagnosed in these regions.


    The largest number of cases of traffic pollution-related asthma were estimated for China (760,000 cases), which is likely a result of China having the second largest population of children and the third highest concentrations of NO2. Although less than half the size of China's burden, India had the next largest number of cases (350,000) due to its large population of children. The USA (240,000), Indonesia (160,000) and Brazil (140,000) had the next largest burdens, with the USA having the highest pollution levels of these three countries, while Indonesia had the highest underlying asthma rates.


    The country with the highest percentage of traffic pollution-attributable childhood asthma incidence was South Korea (31%), followed Kuwait (30%), Qatar (30%), United Arab Emirates (30%), and Bahrain (26%). The UK ranked 24th out of 194 countries, the US 25th, China 19th, and India 58th. The authors explain that India ranks below other countries for this metric because, although levels of other pollutants (particularly PM2.5) in India are among the highest in the world, NO2 levels from 2010-2012 in Indian cities appear to be lower than or comparable to levels in European and US cities.


    Two-thirds of traffic pollution-related asthma cases occurred in urban centres globally, and when suburbs were included this proportion increased to 90% of cases.


    The percentage of new asthma cases attributable to traffic pollution by city ranged from 6% in Orlu, Nigeria, to 48% in Shanghai, China, and largely reflected the variations in NO2 exposures within each region. Of the ten cities with the highest proportion of traffic pollution-related asthma cases, eight were in China (Shanghai, Tianjin, Beijing, Shenyang, Xi'an, Taiyuan, Zhengzhou, and Harbin) alongside Moscow, Russia, and Seoul, South Korea - all of which had high urban NO2 concentrations. Paris ranked 21st (33%), New York ranked 29th (32%), London 35th (29%), and New Delhi 38th (28%).


    The authors note some limitations, including that studies linking traffic pollution and asthma, and NO2 monitoring data are largely from North America, Europe and east Asia, and NO2 ground-level monitors are mostly in urban areas, so could overestimate pollution levels in rural areas.


    Due to limited data availability, the NO2 levels used in this study are for 2010-2012, whereas the population and asthma incidence rates are for 2015. Given recent global changes in NO2 levels (decreases in US and European cities, and increases in Asia), the estimates may not be exact and further research with the latest NO2 levels is needed.


    Writing in a linked Comment, Professor Rajen N Naidoo, University of KwaZulu-Natal, South Africa, says: "An important outcome from this study is the further evidence that the existing WHO standards are not protective against childhood asthma. Achakulwisut and colleagues estimated that approximately 92% of the childhood asthma incidence attributable to NO2 exposure was in areas with NO2 concentrations below the values of the WHO annual average guidelines. This strengthens the case for the downward revision of these global standards and for stronger national policy initiatives in countries without air quality standards. Furthermore, these findings not only support the association of NO2 exposure with childhood asthma incidence, but also, because this pollutant serves as an important proxy for broader traffic related air pollutants, highlight that urgent intervention is necessary to protect the health of those most vulnerable in society: children, particularly those with pre-existing respiratory disease."

    childhood asthmaChinaDr Susan AnenbergGeorge Washington UniversityLancet Planetary HealthPloy AchakulwisutPulmonaryRussiatraffic pollutionWorld Health Organization

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok